Clinical Trials Sponsored by Emilio Ribas Institute of Infectious Diseases

Total 3536 results

University of Sao Paulo General Hospital
Instituto de Infectologia Emílio Ribas

Completed

Correlation Between Cytokines and the Severity of Meningococcal Disease

Meningococcemia

Brazil
Azidus Brasil
Farmoquimica S.A.; Hospital Vera Cruz; Hospital Casa de Saúde - Vera Cruz - Campinas... and other collaborators

Completed

Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19

COVID-19

Brazil
Bamrasnaradura Infectious Diseases Institute
Department of Disease Control, Thailand

Completed

Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure (BIDI-MONO)

HIV | AIDS | Treatment Failure | Lopinavir

Thailand
National Institute of Allergy and Infectious Diseases...
ANRS, Emerging Infectious Diseases

Completed

A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines

HIV Infections

United States
Centre for Infectious Disease Research in Zambia
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Causes of Rotavirus Vaccine Failure in Zambian Children

Diarrhoea

Zambia
National Institute of Allergy and Infectious Diseases...
Infectious Diseases Clinical Research Consortium

Recruiting

A Study of Doxycycline to Treat Chlamydial Infection

Chlamydial Infection

United States, Kenya
National Institute of Allergy and Infectious Diseases...
ANRS, Emerging Infectious Diseases

Completed

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx (ILIADE)

HIV Infections

United States, France
Evandro Chagas National Institute of Infectious...

Completed

Cardiac Rehabilitation in Chagas Heart Failure

Chagas Cardiomyopathy | Chagas Disease

Brazil
National Institute of Allergy and Infectious Diseases...

Recruiting

A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen mRNA-LNP in Healthy Adults

Avian Influenza

United States
National Institute of Allergy and Infectious Diseases...

Not yet recruiting

Treatment of Antibody-Mediated Rejection (ABMR) With CarBel (CarBel)

Kidney Transplant Rejection

United States
National Institute of Allergy and Infectious Diseases...

Not yet recruiting

Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL) (IMPROVE)

Kidney Transplant

United States
National Institute of Allergy and Infectious Diseases...

Not yet recruiting

EVR and EPO for Liver Transplant Tolerance (EVEREST)

Liver Transplant

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health

HIV

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

First-in-Human PfSPZ-LARC2 Vaccination/CHMI

Malaria

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Characterization of Human Immune Signatures to Zoonotic Virus Exposure in Cambodia (Camzoo)

Immunity, Humoral

Cambodia
National Institute of Allergy and Infectious Diseases...

Not yet recruiting

Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in the HVTN706/MOSAICO Study and Remain Without HIV

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

The Tatelo Plus Study

HIV Infections | HIV

Botswana
National Institute of Allergy and Infectious Diseases...

Recruiting

Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients (CLAD)

Lung Transplant

United States, Canada
National Institute of Allergy and Infectious Diseases...

Recruiting

Tocilizumab in Lung Transplantation (ALL IN LUNG)

Lung Transplant

United States, Canada
National Institute of Allergy and Infectious Diseases...

Recruiting

The Study of Immunization in People Living With HIV Undergoing an ATI for Elicitation of VRC01-lineage Antibodies

Chronic HIV Infection

United States
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection

Gonococcal Infection

United States, Thailand, Malawi
National Institute of Allergy and Infectious Diseases...

Withdrawn

CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

Pregnancy | HIV-1-infection | Postpartum

United States, South Africa
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Pharmacokinetics of VRC07-523LS in the Sera and Mucosae of Healthy, HIV-Uninfected Adult Participants (VRC07-523LS)

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Dual bNAb Treatment in Children

HIV Infection

Botswana
National Institute of Allergy and Infectious Diseases...

Completed

Single-Dose Study to Evaluate the PKs of Pretomanid in Participants With Renal Impairment Compared to Participants With Normal Renal Function

Renal Impairment | Tuberculosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase 1 Study of SAR440894 vs Placebo

Chikungunya Virus Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children

RSV Infection

United States
National Institute of Allergy and Infectious Diseases...

Suspended

Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

Tuberculous Meningitis

Tanzania, Thailand, Brazil, India, Kenya, Malawi, Mexico, Peru, Philippines, South Africa, Vietnam, Zimbabwe
National Institute of Allergy and Infectious Diseases...

Completed

A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa

Cystic Fibrosis | Bacterial Disease Carrier

United States
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy (GET IT RIgHT)

HIV I Infection

United States, Thailand, Botswana, Mexico, Peru, South Africa
National Institute of Allergy and Infectious Diseases...

Completed

Dried Blood Spot Testing of CMV Detection in HCT Recipients

Cytomegalovirus Infection

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age

Respiratory Syncytial Virus (RSV)

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of Tofacitinib in Prevention of Photosensitivity in Lupus

Cutaneous Lupus

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Norovirus Challenge Model

Gastroenteritis Norovirus

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of CJCV2 With and Without ALFQ

Campylobacter Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia

Staphylococcal Bacteraemia

United States, Canada
National Institute of Allergy and Infectious Diseases...

Completed

H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses

Influenza | Avian Influenza | H1N1 Influenza

United States
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women

HIV Infections

Zimbabwe, South Africa, Botswana, Kenya, Malawi, Uganda, Swaziland
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Clinical Trial to Evaluate the Safety and Immunogenicity of Ferritin Nanoparticles Expressing Native-like HIV-1 Envelope Trimers Followed by Boost With mRNA Lipid Nanoparticles Encoding a Native-like HIV-1 Envelope Trimer in Adults Without HIV

Hiv

United States
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Siplizumab in T1DM (DESIGNATE)

Type 1 Diabetes Mellitus

United States
National Institute of Allergy and Infectious Diseases...

Completed

Pleconaril Enteroviral Sepsis Syndrome

Enterovirus Infection

United States, Canada
National Institute of Allergy and Infectious Diseases...

Completed

VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents (DNA)

RNA Virus Infections | Virus Diseases | Flavivirus Infections | Flaviviridae Infections | Zika Virus Infection | Zika Virus | Flaviviral Diseases

United States, Puerto Rico, Mexico, Brazil, Colombia, Costa Rica, Ecuador, Panama, Peru
National Institute of Allergy and Infectious Diseases...

Completed

An Observational Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis in Persons Aged > / = 14 Years Presenting With Community Acquired Pneumonia (CAP) in Endemic Areas (SAnds-PPC)

Pneumonia | Coccidioidomycosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza Strain

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers

Influenza | Influenza Immunisation

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Analysis of Bone Marrow and Blood B Cell Immune Responses to Influenza Vaccination

Influenza | Influenza Immunisation

United States
National Institute of Allergy and Infectious Diseases...

Completed

Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients

HIV Infections | Kidney Diseases

United States
US Army Medical Research Institute of Infectious...

Completed

Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever Vaccine

Yellow Fever Vaccination Reaction

United States
National Institute of Allergy and Infectious Diseases...

Completed

Acceptability, Safety, and Use of Daily Truvada Pre-Exposure Prophylaxis in Adolescents

HIV Infections

South Africa
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female Population

HIV Infections

South Africa, Uganda, Zimbabwe

Clinical Trials Sponsored by Emilio Ribas Institute of Infectious Diseases

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations